NSTEMI

Clinical trials for NSTEMI explained in plain language.

Never miss a new study

Get alerted when new NSTEMI trials appear

Sign up with your email to follow new studies for NSTEMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2

Could a diabetes pill mend hearts after a heart attack?

Disease control Recruiting now

This study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help prevent further heart damage in people who have had a major heart attack. About 450 adults with weakened heart pumping function will receive either the drug or a placebo for 6 mon…

Matched conditions: NSTEMI

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 29, 2026 15:04 UTC

NSTEMI

Get alerted when new NSTEMI trials appear

Could a diabetes pill mend hearts after a heart attack?